Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4854-4859

  Pan, Quintin ^a   Kleer, Celina G ^a   Van Golen, Kenneth L ^a   Irani, Jennifer ^a   Bottema, Kristen M ^a   Bias, Carlos ^b   De Carvalho, Magda ^b   Mesri, Enrique A ^b   Robins, Diane M ^a   Dick, Robert D ^a   Brewer, George J ^a   Merajver, Sofia D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TETRATHIOMOLYBDIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; COPPER DEFICIENCY; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MORBIDITY; NUDE MOUSE; ONCOGENE NEU; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VASCULARIZATION; XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; COPPER; DISEASE MODELS, ANIMAL; FEMALE; GENES, ERBB-2; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICE, TRANSGENIC; MOLYBDENUM; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036733754     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Copper stimulates proliferation of human endothelial cells under culture
2. Endothelial cell phagokinesis in response to specific metal ions
3. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor
4. Quantitative analysis of copper, zinc and copper/zinc ration in selected human brain tumors
5. Initial therapy of patients with Wilson’s disease with tetrathiomolybdate
6. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma
7. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study
8. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells
9. Inflammatory breast cancer: A review
10. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation
11. Activation of interleukin-6 gene expression through the NF-κ B transcription factor
12. NF-κ B subunit-specific regulation of the interleukin-8 promoter
13. 12-O-tetradecanoylphorbol-13-ace
14. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1)
15. A labile repressor acts through the NFκB-like binding sites of the human urokinase gene
16. Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
17. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
18. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
19. NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α
20. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1α
21. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells
22. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
23. Correlation between c-rebB-2 amplification and risk of recurrent disease in node-negative breast cancer
24. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
25. Oncogenic Neu/ErbB-2 increases ets. AP-1, and NF-κB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation
26. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway
27. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
28. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB